News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
142,834 Results
Type
Article (2370)
Company Profile (4)
Press Release (140458)
Multimedia
Podcasts (48)
Webinars (4)
Section
Business (47263)
Career Advice (152)
Deals (8276)
Drug Delivery (14)
Drug Development (19282)
Employer Resources (15)
FDA (2999)
Job Trends (3306)
News (70957)
Policy (5161)
Tag
2027 BioCapital Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (138)
Accelerated approval (33)
ADA (11)
Adcomms (1)
Allergies (86)
Alliances (6563)
ALS (116)
Alzheimer's disease (549)
Antibody-drug conjugate (ADC) (291)
Approvals (3568)
Artificial intelligence (380)
ASCO (129)
Autoimmune disease (219)
Automation (39)
Bankruptcy (76)
Belgium (10)
Best Places to Work (3240)
BIO (28)
Biologics (34)
BIOSECURE Act (4)
Biosimilars (110)
BioSpace Insights (16)
Biotechnology (5)
Bispecific (21)
Bladder cancer (170)
Brain cancer (24)
Breast cancer (464)
Cancer (3570)
Cardiovascular disease (248)
Career advice (115)
Career pathing (7)
CAR-T (155)
CDC (7)
CDMO (31)
Celiac Disease (2)
Cell therapy (450)
Cervical cancer (30)
Clinical research (20992)
Collaboration (1155)
Commercialization (23)
Company closure (1)
Compensation (689)
Complete response letters (32)
COVID-19 (407)
CRISPR (55)
C-suite (661)
Cystic fibrosis (68)
Data (5372)
Decentralized trials (1)
Depression (72)
Dermatology (117)
Diabetes (275)
Diagnostics (2109)
Digital health (22)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (168)
Drug pricing (24)
Drug shortages (8)
Duchenne muscular dystrophy (179)
Earnings (35184)
Editorial (15)
Employer branding (1)
Employer resources (6)
ESMO (218)
Events (21669)
Executive appointments (607)
Eye disease (5)
FDA (5435)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (5)
Friedreich's ataxia (14)
Frontotemporal dementia (15)
Funding (860)
Gene editing (109)
Generative AI (18)
Gene therapy (297)
GLP-1 (329)
Government (382)
Grass and pollen (3)
Guidances (311)
Healthcare (3293)
Hematology (74)
HIV (69)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (80)
Immunology and inflammation (104)
Immuno-oncology (58)
Indications (127)
Infectious disease (551)
Inflammatory bowel disease (112)
Inflation Reduction Act (5)
Influenza (54)
Intellectual property (146)
Interviews (40)
IPO (5095)
IRA (4)
Job creations (347)
Job search strategy (86)
JPM (10)
Kidney cancer (15)
Kidney disease (71)
Labor market (47)
Layoffs (109)
Leadership (4)
Legal (835)
Licensing (35)
Liver cancer (37)
Longevity (17)
Lung cancer (522)
Lung diease (8)
Lymphoma (274)
Machine learning (30)
Management (1)
Manufacturing (516)
Marketing (27)
MASH (87)
Medical affairs (5)
Medical device (2846)
Medtech (2941)
Mergers & acquisitions (4025)
Metabolic disorders (644)
mRNA (57)
Multiple sclerosis (81)
Multispecific (3)
NASH (3)
Netherlands (7)
Neurodegenerative disease (238)
Neuropsychiatric disorders (52)
Neuroscience (1374)
Neurotech (2)
NextGen: Class of 2026 (702)
Non-profit (138)
Now hiring (16)
Obesity (279)
Opinion (35)
Ovarian cancer (167)
Pain (108)
Pancreatic cancer (204)
Parkinson's disease (191)
Partnered (5)
Patents (295)
Patient advocacy (3)
Patient recruitment (429)
Patient selection (43)
Peanut (23)
People (8215)
Peptides (14)
Pharmaceutical (3)
Pharmacy benefit managers (10)
Phase 1 (6401)
Phase 2 (9193)
Phase 3 (7416)
Pipeline (7423)
Policy (27)
Postmarket research (387)
Preclinical (1999)
Press Release (8)
Prostate cancer (190)
Psychedelics (12)
Radioligand (1)
Radiopharmaceuticals (110)
Rare diseases (554)
Real estate (481)
Recruiting (4)
Regenerative medicine (14)
Regulatory (6612)
Reports (36)
Research institute (177)
Resumes & cover letters (32)
Rett syndrome (46)
RNA editing (9)
RSV (48)
Schizophrenia (110)
Series A (138)
Series B (106)
Sickle cell disease (35)
Special edition (15)
Spinal muscular atrophy (67)
Sponsored (9)
Startups (224)
State (1)
Stem cells (5)
Stomach cancer (1)
Substance use disorders (8)
Supply chain (59)
Switzerland (1)
Tariffs (22)
The Weekly (48)
Vaccines (284)
Venture capital (26)
Weight loss (152)
Wet AMD (3)
Women's health (85)
Worklife (2)
Date
Today (60)
Last 7 days (341)
Last 30 days (1433)
Last 365 days (14553)
2026 (12089)
2025 (14697)
2024 (11811)
2023 (10773)
2022 (11581)
2021 (11831)
2020 (11183)
2019 (6889)
2018 (5162)
2017 (5985)
2016 (4746)
2015 (6061)
2014 (4190)
2013 (2637)
2012 (2951)
2011 (3238)
2010 (2983)
Location
Africa (62)
Alabama (36)
Arizona (104)
Arkansas (5)
Asia (5537)
Australia (933)
California (9126)
Canada (1369)
China (498)
Colorado (327)
Connecticut (384)
Delaware (355)
Europe (15905)
Florida (1156)
Georgia (187)
Hawaii (4)
Idaho (5)
Illinois (681)
India (42)
Indiana (353)
Iowa (12)
Japan (462)
Kansas (17)
Kentucky (13)
Louisiana (22)
Maine (65)
Maryland (731)
Massachusetts (6027)
Michigan (146)
Minnesota (325)
Missouri (64)
Montana (5)
Nebraska (2)
Nevada (114)
New Hampshire (25)
New Jersey (2081)
New Mexico (7)
New York (1796)
North Carolina (758)
North Dakota (5)
Northern California (4805)
Ohio (190)
Oklahoma (9)
Oregon (11)
Pennsylvania (1300)
Puerto Rico (14)
Rhode Island (18)
South America (126)
South Carolina (37)
Southern California (3540)
Tennessee (119)
Texas (1484)
United States (28261)
Utah (250)
Virginia (232)
Washington D.C. (23)
Washington State (713)
West Virginia (1)
Wisconsin (125)
142,834 Results for "q straint".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Bonus: Q3 2026 Job Market Update
In this bonus episode,
BioSpace
Vice President of Marketing Chantal Dresner and Angela Gabriel, content manager, life sciences careers, discuss how the job market shaped up in Q3 and what Q4 might hold.
October 20, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Report: Biopharma Job Market Report Q3 2026
The third quarter offered positive signals for job seekers and talent acquisition teams. Explore BioSpace’s Biopharma Job Market Report Q3 2026 to get a closer look at hiring trends, workforce reductions and the evolving employment landscape across the industry.
October 20, 2026
·
1 min read
·
BioSpace Insights
Job Trends
Q3 layoffs down YOY, with 90% fewer biopharma employees affected
Big Pharma companies including Bristol Myers Squibb, Johnson & Johnson and Novartis are among those that made or planned layoffs in Q3. Those cuts could affect over 1,800 employees, with New Jersey the hardest-hit state.
October 8, 2026
·
6 min read
·
Angela Gabriel
Career Advice
Urgency, flexibility during Q4 job search among keys to success
Based on typical fourth quarter hiring activity, biopharma job seekers should apply for open roles sooner than later. Recruiting and career coaching experts offer advice on timing, networking, interviewing and casting a wider net than usual during Q4.
October 1, 2026
·
4 min read
·
Angela Gabriel
Job Trends
Bonus: Q2 2026 Job Market Update
In this bonus episode,
BioSpace
Managing Editor Jef Akst and Angela Gabriel, content manager, life sciences careers, look at the Q2 job market and discuss encouraging signs for job seekers.
July 14, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Report: Biopharma Job Market Report Q2 2026
Gain the latest insights into the biopharma hiring landscape with BioSpace’s Biopharma Job Market Report Q2 2026. Explore the trends shaping talent acquisition, from rising job postings and sustained R&D hiring to the market activity signaling stronger hiring demand ahead.
July 13, 2026
·
1 min read
·
BioSpace Insights
Press Releases
EssilorLuxottica: Q3 2026 Revenue - Revenue growth at 9.0% in Q3, +7.2% at constant currency
October 20, 2026
·
2 min read
Job Trends
Biopharmas pull back on layoffs in Q1
The trend of fewer companies letting employees go, which began in the fourth quarter of last year, has continued. However, more employees were on the chopping block in Q1 2026 than in Q1 2025, due mainly to one company’s cuts.
April 16, 2026
·
4 min read
·
Angela Gabriel
Press Releases
Precipio Announces Q3-2026 Shareholder Update Call
October 29, 2026
·
4 min read
Press Releases
AstraZeneca results: 9M and Q3 2026
October 30, 2026
·
10 min read
1 of 14,284
Next
